Activation Platform
Drive awareness, engagement, and real-world action with patients
Company profile
Company profile
Evidation is a health data platform company that connects directly with millions of individuals to transform real-world health experiences into scientific insights. Founded in 2012 and headquartered in San Mateo, California, Evidation maintains ongoing engagement with 5 million people across 97% of U.S. ZIP codes who participate in a consented, mutual value exchange. The company collects longitudinal, multimodal real-world data including clinical data (EHR and claims), demographic and social context, conditions and treatment experience, patient-reported outcomes, molecular data from biosamples, and digital measures from wearables. This comprehensive data provides the depth and temporal context needed for better insights, evidence generation, and model development. Evidation serves life sciences companies, consumer health companies, government agencies, and non-profit organizations by enabling research, discovery, early development, evidence generation, medical value demonstration, and commercial planning. The platform has supported over 140 real-world studies and contributed to over 100 peer-reviewed publications. More than 90% of top biopharma companies have partnered with Evidation. The company's approach captures continuous data that reflects how patients manage conditions, experience treatment, and change between clinical visits—information that traditional real-world data sources miss. Through the Evidation app, individuals control what data they share, with whom, and for how long, while receiving personalized insights and earning rewards for their participation.
Company description Evidation official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Recorded integration context: 1upHealth, Apple Watch, Claims data, EHR systems, iPhone, Wearable devices.
Company milestones
Launched Interactive Dermatology Cohort (2024-2025), Launched Temporal Proteomics Platform for autoimmune research (2024-2025), Shared insights on real-world GLP-1 dosing behaviors from 60,000+ individuals (2024-2025), Appointed Dr. Ghazanfar Khan as Chief Medical Officer (2024-2025), Appointed Leslie Oley Wilberforce as CEO (2024-2025), Partnership with 1upHealth announced (2024-2025)
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Drive awareness, engagement, and real-world action with patients
Share health data with researchers, get insights, and earn rewards
Real-world insights on dermatology treatment journeys and outcomes
Understand patient needs, preferences, and decision drivers
Sponsor-driven observational research with longitudinal data collection
Longitudinal, multimodal real-world data from direct patient connections
Find and enroll the right trial participants from engaged community
White-label platform for multi-year research programs with high engagement
AI-enabled platform for autoimmune biomarker discovery and modeling
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
JMIR formative research · Apr 28, 2026
Model-Twin Randomization (MoTR) for Estimating the Recurring Individual Treatment Effect.Statistics in medicine · Nov 1, 2025
American Life in Realtime: Benchmark, publicly available person-generated health data for equity in precision health.PNAS nexus · Oct 1, 2025
Using Social Media to Engage and Enroll Underrepresented Populations: Longitudinal Digital Health Research.JMIR formative research · Apr 15, 2025
Psychometric properties of the Federal Unit Scale for general psychopathology screening without iatrogenic effects.Journal of psychiatric research · Apr 1, 2025
Identification of key factors related to digital health observational study adherence and retention by data-driven approaches: an exploratory secondary analysis of two prospective longitudinal studies.The Lancet. Digital health · Jan 1, 2025
Clinical validation
NCT07075341 · Sponsor · RECRUITING
A Study to Investigate if Early Atrial Fibrillation (AF) Diagnosis Reduces Risk of Events Like Stroke in the Real-WorldNCT04276441 · Mentioned · COMPLETED
Research and Engagement on Substance Use: Harnessing Awareness and Personalized Education (RESHAPE) to Improve Well-being and Self-efficacyNCT06952491 · Sponsor · ENROLLING BY INVITATION
Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILINCT06229444 · Sponsor · COMPLETED
Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral InfectionsNCT06207929 · Sponsor · COMPLETED
Evaluation of a Digital Diabetes Self-Management Education and Support ProgramNCT05368454 · Sponsor · COMPLETED
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Participant retention in research programs
Content engagement in app
Research study adherence
Long-term study participation
Type 2 diabetes flu vaccine education program with Sanofi
Heart Health patient engagement program to allow cardiovascular patients to track everyday health and proactively manage care beyond traditional clinical settings
33,000 participants joined; 87% of individuals who shared personalized insights report with care team found it helpful or extremely helpful
FluSmart flu monitoring program to collect rich, longitudinal data and activate high-risk participants into research and care
200,000+ individuals participated with 90%+ engagement rate
Study to demonstrate that person-generated health data from smartphones and wearables can enable early warnings and population-level hotspot detection for COVID-19
800+ individuals recruited with >80% compliance with study activities
Multi-year observational study to assess whether the Heartline Study app on iPhone and Apple Watch can reduce stroke likelihood and improve health outcomes with earlier detection of atrial fibrillation
30,000+ participants aged 65+ enrolled
4-month direct-to-patient study to uncover significant unmet needs among individuals with uterine fibroids
350 women with uterine fibroids enrolled; 92% weekly survey completion and 85% daily survey completion
Pilot study to demonstrate value of digital hypertension self-management program by quantifying impact on blood pressure control
151 individuals with hypertension recruited; published evidence that app improves blood pressure and medication adherence
Test and refine content and messaging for Type 2 diabetes flu vaccine education program to increase treatment rates
10,000 individuals recruited; up to 2x increase in vaccination rates for participants who engaged with customized diabetes campaign vs. generic messaging
American Life in Real-time (ALiR) - first-of-its-kind, publicly available benchmark registry and research infrastructure for person-generated health data from smartphones and wearables
Digital engagement program launched to more than 1,000 participants
05 · Leadership
Leadership profiles and professional links from the current Company record.
Leslie Oley Wilberforce
CEO
Dr. Ghazanfar Khan
Chief Medical Officer
06 · Company updates
Recent articles published on Evidation's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.